The SPP1 mutation frequency was the primary alteration in uterine tumors, melanoma, stomach tumors, cervical tumors, lung squamous cell carcinoma, colorectal tumors, lung adenocarcinoma, GBM, HNSC, ccRCC, and LGG. This evidence concerns the gene SPP1 and nonpapillary renal cell carcinoma.